Enlaza Therapeutics

📍 San Diego, United States👥 54 employees💰 Last funded Aug 2024
Biotechnology Research🌐 enlazatx.com
Website LinkedIn
Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Enlaza Therapeutics?
Enlaza Therapeutics has 1 investors on record on gritt.io.
When did Enlaza Therapeutics last raise funding?
The most recent investment in Enlaza Therapeutics recorded on gritt.io was in August 2024.
What industry is Enlaza Therapeutics in?
Enlaza Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Enlaza Therapeutics based?
Enlaza Therapeutics is headquartered in San Diego, United States.